IRB’s and patients’ views on consent for research on medical practices

In the context of research on medical practices, which includes comparative effectiveness research and pragmatic clinical trials, empirical studies have begun to raise questions about the extent to which institutional review boards’ interpretations and applications of research regulations align with patients’ values. David Magnus, PhD is Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics and Medicine at Stanford University, where he is Director of the Stanford Center for Biomedical Ethics and co-Chair of the Ethics Committee for the Stanford Hospital. He is the former President of the Association of Bioethics Program Directors, and is the Editor in Chief of the American Journal of Bioethics.

Publication

 

 

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
You may have unlimited institutional access to Faculti. Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access this site through your SSO/EZproxy/IP address. This should permit you with unlimited views. However, you will not be able to view non-subscribed to content.

If you are not affiliated with a subscribing institution, you can register for free as an individual and view thousands of insights in our archive today or subscribe for subject access.

In addition, all guest visitors to the Faculti website can view any insight monthly. You have insight(s) remaining for this month.
Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×